CareLit · DOI-Nachweis · Klinische Pädiatrie
Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study
DOI 10.1055/s-0034-1371126
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC Mauz-Körholz, D Hasenclever, V Holzendorf, H Jürgens, S Burdach, A Eggert, F Berthold, H Müller, M Frühwald, T Klingebiel, M Metzler, D Körholz
ZeitschriftKlinische Pädiatrie
Ausgabe03/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Purpose: The VECOPA (vinblastine, etoposide, cyclophosphamide, vincristine, prednisone, doxorubicine) – consolidation cycle was designed to intensify the COPDAC (cyclophosphamide, vincristine, prednisone, dacarbazine) consolidation cycle as a potential alternative procarbazine-free regimen. VECOPA was thus piloted in boys with Hodgkin's Lymphoma (HL) as a 42 days instead of a 58 days regimen. Patients & Methods: Fol…
Zitieren
Zitierempfehlung
C Mauz-Körholz, D Hasenclever, V Holzendorf, H Jürgens, S Burdach, A Eggert, F Berthold, H Müller, M Frühwald, T Klingebiel, M Metzler, D Körholz (2014) Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study. Klinische Pädiatrie (03). https://doi.org/10.1055/s-0034-1371126
Mit CareLit weiterarbeiten